In last trading session, Biolase Inc (NASDAQ:BIOL) saw 0.73 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $0.14 trading at -$0.01 or -1.10% at ring of the bell on the day assigns it a market valuation of $4.80M. That closing price of BIOL’s stock is at a discount of -7264.29% from its 52-week high price of $10.31 and is indicating a premium of 7.14% from its 52-week low price of $0.13. Taking a look at company’s average trading volume volume of 4.78 million if we extend that period to 3-months.
Biolase Inc (NASDAQ:BIOL) trade information
Upright in the red during last session for losing -1.10%, in the last five days BIOL remained trading in the red while hitting it’s week-highest on Tuesday, 06/11/24 when the stock touched $0.14 price level, adding 10.26% to its value on the day. Biolase Inc’s shares saw a change of -87.20% in year-to-date performance and have moved -0.97% in past 5-day. Biolase Inc (NASDAQ:BIOL) showed a performance of -6.63% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biolase Inc (BIOL) estimates and forecasts
This year revenue growth is estimated to rise 3.10% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 13.49M for the same. And 3 analysts are in estimates of company making revenue of 11.58M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 59.23% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 98.51% while estimates for its earnings growth in next 5 years are of 20.00%.
BIOL Dividends
Biolase Inc is more likely to be releasing its next quarterly report in July and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
